SS
IRWD icon

Simplicity Solutions’s Ironwood Pharmaceuticals IRWD Stock Holding History

Simplicity Solutions’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-24,784
Closed -$241K – 346
2015
Q4 		$241K Buy
+24,784
New +$240K 0.03% 567

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Simplicity Solutions's IRWD Position: Q1 2016 in Review

Simplicity Solutions sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2016, closing a stake of 24,784 shares — an estimated $241K sold.

Simplicity Solutions first reported a position in IRWD in Q4 2015 and held it in 1 quarter. The position peaked at $241K in Q4 2015. 136 funds tracked by Wall St. Rank hold IRWD as of Q1 2016.

  • Simplicity Solutions reported no remaining Ironwood Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Simplicity Solutions sold 24,784 Ironwood Pharmaceuticals shares in Q1 2016, an estimated $241K.
  • Simplicity Solutions first reported a position in Ironwood Pharmaceuticals in Q4 2015 and held it in 1 quarter.
  • Simplicity Solutions's Ironwood Pharmaceuticals position peaked at $241K in Q4 2015.
  • 136 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2016.

Based on Simplicity Solutions's 13F filing for Q1 2016, filed 26 Apr 2016.